Histrelin subcutaneous implant    (DrugBank: Histrelin)

1 disease
IDDisease name (Link within this page)Number of trials
76Pituitary gonadotropin secretion hyperthyroidism1

76. Pituitary gonadotropin secretion hyperthyroidism    [ 25 clinical trials,   41 drugs,   (DrugBank: 11 drugs),   3 drug target genes,   10 drug target pathways]
Searched query = "Pituitary gonadotropin secretion hyperthyroidism", "Gonadotropin secreting pituitary adenoma", "Central precocious puberty", "Gonadotropin producing pituitary adenoma"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 25 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00779103
(ClinicalTrials.gov)
September 200422/10/2008Histrelin Subcutaneous Implant in Children With Central Precocious PubertyPhase III, Open-Label Study to Evaluate Efficacy and Safety of Histrelin Subdermal Implant in Children With Central Precocious PubertyCentral Precocious PubertyDrug: Histrelin Subcutaneous ImplantEndo PharmaceuticalsNULLCompleted2 Years10 YearsBoth36Phase 3NULL